Phenylbutyrate (PB) acts as chemical chaperone and histone deacetylase inhibitor, which is used to decrease ammonia in urea cycle disorders and has been investigated for use in the treatment of a number of lethal illnesses. We performed in vivo and in vitro experiments to examine the effects of PB on glutamine (GLN), branched-chain amino acid (BCAA; valine, leucine and isoleucine) and protein metabolism in rats. In the first study, animals were sacrificed one hour after three injections of PB (300mg/kg b.w.) or saline. In the second study, soleus (SOL, slow twitch) and extensor digitorum longus (EDL, fast twitch) muscles were incubated in a medium with or without PB (5 mM). L-[1-14 C] leucine was used to estimate protein synthesis and leucine oxidation, and 3-methylhistidine release was used to evaluate myofibrillar protein breakdown. PB treatment decreased GLN, BCAA and branched-chain keto acids (BCKAs) in blood plasma, decreased BCAA and increased GLN concentrations in muscles, and increased GLN synthetase activities in muscles. Addition of PB to incubation medium increased leucine oxidation (55% in EDL, 29% in SOL), decreased BCKA and increased GLN in medium of both muscles, increased GLN in muscles, decreased protein synthesis in SOL and increased proteolysis in EDL. It is concluded that PB decreases BCAA, BCKA and GLN in blood plasma, activates BCAA catabolism and GLN synthesis in muscle and exerts adverse effects on protein metabolism. The results indicate that BCAA and GLN supplementation is needed when PB is used therapeutically and that PB may be a useful prospective agent which could be effective in management of maple syrup urine disease.

Department of Biochemistry Faculty of Medicine Charles University Hradec Kralove Czech Republic

Department of Physiology Faculty of Medicine Charles University Hradec Kralove Czech Republic

Zobrazit více v PubMed

Bergström J., Fürst P., Norée L.O. et al (1974) Intracellular free amino acid concentration in human muscle tissue. J. Appl. Physiol. 36, 693–697. PubMed

Brunetti‐Pierri N., Lanpher B., Erez A. et al (2011) Phenylbutyrate therapy for maple syrup urine disease. Hum. Mol. Genet. 20, 631–640. PubMed PMC

Buchman A.L. (1999) Glutamine for the gut: mystical properties or an ordinary amino acid? Curr. Gastroenterol. Rep. 1, 417–423. PubMed

Carducci M.A., Nelson J.B., Chan‐Tack K.M. et al (1996) Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin. Cancer Res. 2, 379–387. PubMed

Davies N.A., Wright G., Ytrebø L.M. et al (2009) L‐ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats. Hepatology 50, 155–164. PubMed

Exner R., Weingartmann G., Eliasen M.M. et al (2002) Glutamine deficiency renders human monocytic cells more susceptible to specific apoptosis triggers. Surgery 131, 75–80. PubMed

Graham J.A., Lamb J.F. & Linton A.L. (1967) Measurement of body water and intracellular electrolytes by means of muscle biopsy. Lancet 2, 1172–1176. PubMed

Hardy G. & Hardy I.J. (2008) Can glutamine enable the critically ill to cope better with infection? JPEN J. Parenter. Enteral Nutr. 32, 489–491. PubMed

Holecek M. (2001) The BCAA‐BCKA cycle: its relation to alanine and glutamine synthesis and protein balance. Nutrition 17, 70. PubMed

Holecek M. (2011) Branched‐chain amino acid oxidation in skeletal muscle ‐ physiological and clinical importance of its modulation by reactant availability. Curr Nutr Food Sci 7, 50–56.

Holecek M. & Sispera L. (2014) Glutamine deficiency in extracellular fluid exerts adverse effects on protein and amino acid metabolism in skeletal muscle of healthy, laparotomized, and septic rats. Amino Acids 46, 1377–1384. PubMed

Holecek M. & Vodenicarovova M. (2016) Phenylbutyrate exerts adverse effects on liver regeneration and amino acid concentrations in partially hepatectomized rats. Int. J. Exp. Pathol. 97, 278–284. PubMed PMC

Holecek M., Sprongl L., Skopec F. et al (1997) Leucine metabolism in TNF‐alpha‐ and endotoxin‐treated rats: contribution of hepatic tissue. Am. J. Physiol. 273, E1052–E1058. PubMed

Holecek M., Sprongl L., Tichy M. et al (1998) Leucine metabolism in rat liver after a bolus injection of endotoxin. Metabolism 47, 681–685. PubMed

Holecek M., Sispera L. & Skalska H. (2015) Enhanced glutamine availability exerts different effects on protein and amino acid metabolism in skeletal muscle from healthy and septic rats. JPEN J. Parenter. Enteral Nutr. 39, 847–854. PubMed

Iannitti T. & Palmieri B. (2011) Clinical and experimental applications of sodium phenylbutyrate. Drugs R D 11, 227–249. PubMed PMC

Kadlcikova J., Holecek M., Safranek R. et al (2004) Effects of proteasome inhibitors MG132, ZL3VS and AdaAhx3L3VS on protein metabolism in septic rats. Int. J. Exp. Pathol. 85, 365–371. PubMed PMC

Kimball S.R. & Jefferson L.S. (2001) Regulation of protein synthesis by branched‐chain amino acids. Curr. Opin. Clin. Nutr. Metab. Care 4, 39–43. PubMed

Lowry O.H., Rosebrough N.J., Farr A.L. et al (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275. PubMed

Maizels E.Z., Ruderman N.B., Goodman M.N. et al (1977) Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat. Biochem. J. 162, 557–568. PubMed PMC

Minet R., Villie F., Marcollet M. et al (1997) Measurement of glutamine synthetase activity in rat muscle by a colorimetric assay. Clin. Chim. Acta 268, 121–132. PubMed

Mokhtarani M., Diaz G.A., Rhead W. et al (2013) Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. Mol. Genet. Metab. 110, 446–453. PubMed PMC

Muthny T., Kovarik M., Sispera L. et al (2008) Protein metabolism in slow‐ and fast‐twitch muscle during turpentine‐induce inflammation. Int. J. Exp. Pathol. 89, 64–71. PubMed PMC

Muthny T., Kovarik M., Sispera L. et al (2009) The effect of new proteasome inhibitors, belactosin A and C, on protein metabolism in isolated rat skeletal muscle. J. Physiol. Biochem. 65, 137–146. PubMed

Nair K.S. & Short K.R. (2005) Hormonal and signaling role of branched‐chain amino acids. J. Nutr. 135, 1547S–1552S. PubMed

O'Donnel T.F., Clowes G.H., Blackburn G.L. et al (1976) Proteolysis associated with a deficit of peripheral energy fuel substrates in septic man. Surgery 80, 192–200. PubMed

Perrine S.P., Wargin W.A., Boosalis M.S. et al (2011) Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double‐blind, placebo‐controlled, single‐dose, and repeat‐dose studies in healthy volunteers. J. Clin. Pharmacol. 51, 1186–1194. PubMed PMC

Safranek R., Holecek M., Kadlcikova J. et al (2003a) Method of measurement of protein metabolism in isolated skeletal muscle of the rat. Acta Medica. (Hradec Kralove) Suppl. 46, 33–37. PubMed

Safranek R., Holecek M., Kadlcikova J. et al (2003b) Effect of acute acidosis on protein and amino acid metabolism in rats. Clin. Nutr. 22, 437–443. PubMed

Stadtman E.R. (2001) The story of glutamine synthetase regulation. J. Biol. Chem. 276, 44357–44364. PubMed

Tischler M.E., Desautels M. & Goldberg A.L. (1982) Does leucine, leucyl‐tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J. Biol. Chem. 257, 1613–1621. PubMed

Walser M. (1984) Therapeutic aspects of branched‐chain amino and keto acids. Clin. Sci. (Lond.) 66, 1–15. PubMed

Muscle Amino Acid and Adenine Nucleotide Metabolism during Exercise and in Liver Cirrhosis: Speculations on How to Reduce the Harmful Effects of Ammonia

The role of skeletal muscle in the pathogenesis of altered concentrations of branched-chain amino acids (valine, leucine, and isoleucine) in liver cirrhosis, diabetes, and other diseases

Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements